Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
ENDRA Life Sciences Inc. (NDRA) had Free Cash Flow per Share of $-3.38 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-1.23M |
|
-- |
|
-- |
|
$1.30M |
|
$-1.30M |
|
$0.08M |
|
$-1.23M |
|
$-1.23M |
|
$-1.23M |
|
$-1.23M |
|
$-1.23M |
|
$-1.23M |
|
$-1.30M |
|
$-1.27M |
|
0.72M |
|
0.72M |
|
$-1.71 |
|
$-1.71 |
|
| Balance Sheet Financials | |
$1.85M |
|
$0.06M |
|
$0.95M |
|
$2.81M |
|
$0.58M |
|
-- |
|
$0.76M |
|
$1.33M |
|
$1.47M |
|
$1.47M |
|
$1.47M |
|
0.75M |
|
| Cash Flow Statement Financials | |
$-2.41M |
|
$-0.02M |
|
$1.00M |
|
$3.23M |
|
$1.81M |
|
$-1.42M |
|
$0.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.21 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.42M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-83.22% |
|
-83.22% |
|
-43.66% |
|
-83.22% |
|
$1.96 |
|
|
Free Cash Flow per Share |
$-3.38 |
$-3.36 |
|